Exhaled breath analysis in interstitial lung disease.

Area of Science:

• Pulmonary Medicine
• Biomarker Discovery
• Analytical Chemistry

Background:

• Interstitial lung disease (ILD) diagnosis and prognosis require improved noninvasive tools.
• Volatile organic compounds (VOCs) in exhaled breath offer potential as novel biomarkers for ILD.
• Breath analysis provides a noninvasive window into a patient's physiological state.

Approach:

• This review summarizes the fundamental principles of breath analysis techniques.
• It examines existing evidence on exhaled breath analysis in the context of ILD.
• Future research directions and clinical applications are discussed.

Key Points:

• Gas chromatography-mass spectrometry and electronic nose technology are primary methods for exhaled breath analysis in ILD.
• Most studies indicate high diagnostic accuracy for ILD, though methodologies vary significantly.
• Ongoing research explores the use of electronic nose technology for predicting treatment response and disease progression.

Conclusions:

• Exhaled breath analysis shows significant promise for the diagnosis of ILD.
• Current evidence suggests high diagnostic potential, but lacks validation.
• Larger, prospective, longitudinal studies employing standardized methods are essential for clinical adoption.